Mirroring our CD8+ TEX signature analysis, Thorsson et al. demonstrated IFN-γ signature–enriched tumors to be most frequent in TNBC, followed by luminal B BC and then luminal A BC (50). The gene discussed is CD8A; the disease is breast cancer.